MetaCap

Innovative Eyewear (LUCY) vs RxSight (RXST)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

RxSight is the larger company by market cap ($187.4 million vs $6.1 million), about 30.6 times the size, while Innovative Eyewear is growing revenue faster (+62.6% vs -3.9%). RxSight converts more of its revenue into profit, with a net margin of -29.0% versus -285.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LUCY-22.97%RXST-6.87%
+14%-5%-25%
Oct 7, 20261 yearNov 20, 2026
LUCY-22.21%RXST-7.07%
+12%-6%-24%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LUCY versus RXST key metrics
MetricLUCYRXST
Share price$0.7025$4.47
Market cap$6.12M$187.42M
1-day change-0.07%-3.04%
YTD return—-57.10%
1-year return—-55.96%
5-year return—-63.86%
EPS (TTM)$-1.17$-1.29
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.66M$134.48M
Revenue growth (YoY)+62.65%-3.89%
Net income (latest FY)$-7.59M$-38.94M
Gross margin21.32%76.60%
Operating margin—-35.84%
Net margin-285.20%-28.96%
52-week high$2.00$13.22
52-week low$0.65$4.11
Distance from 52-week high-64.88%-66.19%
Analyst consensus—hold
Avg. price target upside—+36.47%
Average volume3.52M826.96K
Shares outstanding8.71M41.93M
Employees13461
SectorHealth CareHealth Care
IndustryOphthalmic GoodsOphthalmic Goods

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RxSight is about 30.6 times larger than Innovative Eyewear by market value ($187.42M vs $6.12M).
  • RxSight is more profitable, keeping -29.0 cents of every revenue dollar as net income versus -285.2 cents for Innovative Eyewear.
  • Innovative Eyewear grew revenue faster in its latest fiscal year (+62.65% vs -3.89%).

About Innovative Eyewear

LUCY stock →

Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names.

Health Care · Ophthalmic Goods · 13 employees

About RxSight

RXST stock →

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.

Health Care · Ophthalmic Goods · 461 employees

LUCY vs RXST FAQ

Which is bigger, Innovative Eyewear or RxSight?

RxSight (RXST) is larger, with a market capitalization of $187.42M compared with $6.12M for Innovative Eyewear (LUCY).

Are Innovative Eyewear and RxSight in the same industry?

Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.

More comparisons